FDA panel votes against Spectrum's lung cancer drug

FDA panel votes against Spectrum's lung cancer drug

Submitted by admin on September 22, 2022 - 11:54pm
Source: 
Reuters
News Tags: 
FDA
Spectrum Pharrmaceuticals
non-small cell lung cancer
poziotinib
Headline: 
FDA panel votes against Spectrum's lung cancer drug
snippet: 

Advisers to the U.S Food and Drug Administration on Thursday voted against recommending Spectrum Pharmaceuticals' (SPPI.O) experimental drug for the treatment of patients with a form of non-small cell lung cancer.

Do Not Allow Advertisers to Use My Personal information